Fig. 2From: Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitisHeatmap of baseline and time-course immuno-phenotyping in each subset in LVV patients without relapse. Fold change in each immuno-phenotype at baseline and at weeks 4, 12, 24, and 52 of treatment in a GCA (n = 8) and b TAK (n = 5) patients without relapse. LVV, large vessel vasculitis; GCA, giant cell arteritis; TAK, Takayasu arteritisBack to article page